SHOULDER INNOVATIONS INC (SI) Fundamental Analysis & Valuation

NYSE:SI • US82537J1088

Current stock price

14.96 USD
+0.14 (+0.94%)
Last:

This SI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. SI Profitability Analysis

1.1 Basic Checks

  • In the past year SI was profitable.
  • In the past year SI has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: SI reported negative net income in multiple years.
  • In multiple years SI reported negative operating cash flow during the last 5 years.
SI Yearly Net Income VS EBIT VS OCF VS FCFSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M

1.2 Ratios

  • SI has a Return On Assets of -7.20%. This is in the better half of the industry: SI outperforms 65.96% of its industry peers.
  • With a decent Return On Equity value of -8.69%, SI is doing good in the industry, outperforming 69.68% of the companies in the same industry.
Industry RankSector Rank
ROA -7.2%
ROE -8.69%
ROIC N/A
ROA(3y)-18.56%
ROA(5y)-10.68%
ROE(3y)-34.67%
ROE(5y)-16.28%
ROIC(3y)N/A
ROIC(5y)N/A
SI Yearly ROA, ROE, ROICSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • SI's Gross Margin of 76.51% is amongst the best of the industry. SI outperforms 87.23% of its industry peers.
  • SI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SI Yearly Profit, Operating, Gross MarginsSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. SI Health Analysis

2.1 Basic Checks

  • SI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • SI has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, SI has more shares outstanding
  • Compared to 1 year ago, SI has an improved debt to assets ratio.
SI Yearly Shares OutstandingSI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
SI Yearly Total Debt VS Total AssetsSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • SI has an Altman-Z score of 6.27. This indicates that SI is financially healthy and has little risk of bankruptcy at the moment.
  • SI has a Altman-Z score of 6.27. This is amongst the best in the industry. SI outperforms 80.85% of its industry peers.
  • SI has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.11, SI is in the better half of the industry, outperforming 65.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 6.27
ROIC/WACCN/A
WACC5.65%
SI Yearly LT Debt VS Equity VS FCFSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 11.07 indicates that SI has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 11.07, SI belongs to the best of the industry, outperforming 95.74% of the companies in the same industry.
  • A Quick Ratio of 9.55 indicates that SI has no problem at all paying its short term obligations.
  • SI's Quick ratio of 9.55 is amongst the best of the industry. SI outperforms 93.62% of its industry peers.
Industry RankSector Rank
Current Ratio 11.07
Quick Ratio 9.55
SI Yearly Current Assets VS Current LiabilitesSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. SI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 27.34% over the past year.
  • The Earnings Per Share has been growing by 43.54% on average over the past years. This is a very strong growth
  • The Revenue for SI has decreased by -20.50% in the past year. This is quite bad
  • SI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.05% yearly.
EPS 1Y (TTM)27.34%
EPS 3Y21.76%
EPS 5Y43.54%
EPS Q2Q%245.08%
Revenue 1Y (TTM)-20.5%
Revenue growth 3Y16.94%
Revenue growth 5Y25.05%
Sales Q2Q%-54.41%

3.2 Future

  • Based on estimates for the next years, SI will show a very negative growth in Earnings Per Share. The EPS will decrease by -18.12% on average per year.
  • SI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.68% yearly.
EPS Next Y-90.2%
EPS Next 2Y-47.1%
EPS Next 3Y-37.25%
EPS Next 5Y-18.12%
Revenue Next Year124.61%
Revenue Next 2Y53.95%
Revenue Next 3Y27.81%
Revenue Next 5Y16.68%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SI Yearly Revenue VS EstimatesSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -200M -400M
SI Yearly EPS VS EstimatesSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2

More info and screens

Find the best growth stocksShow best growing peers

4

4. SI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 4.07, the valuation of SI can be described as very cheap.
  • Based on the Price/Earnings ratio, SI is valued cheaper than 98.40% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.78. SI is valued rather cheaply when compared to this.
  • Based on the Price/Forward Earnings ratio of 14.52, the valuation of SI can be described as correct.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of SI indicates a rather cheap valuation: SI is cheaper than 87.23% of the companies listed in the same industry.
  • SI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.54.
Industry RankSector Rank
PE 4.07
Fwd PE 14.52
SI Price Earnings VS Forward Price EarningsSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SI Per share dataSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • A cheap valuation may be justified as SI's earnings are expected to decrease with -37.25% in the coming years.
PEG (NY)N/A
PEG (5Y)0.09
EPS Next 2Y-47.1%
EPS Next 3Y-37.25%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SI Dividend Analysis

5.1 Amount

  • No dividends for SI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SI Fundamentals: All Metrics, Ratios and Statistics

SHOULDER INNOVATIONS INC

NYSE:SI (4/10/2026, 8:04:00 PM)

14.96

+0.14 (+0.94%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-10
Earnings (Next)N/A
Inst Owners71.94%
Inst Owner Change0%
Ins Owners4.03%
Ins Owner Change8.18%
Market Cap308.92M
Revenue(TTM)47.32M
Net Income(TTM)-12.23M
Analysts86.67
Price Target20.91 (39.77%)
Short Float %1.67%
Short Ratio3.56
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-58.12%
Min EPS beat(2)-101.74%
Max EPS beat(2)-14.5%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)12.49%
Min Revenue beat(2)9.41%
Max Revenue beat(2)15.57%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.44%
PT rev (3m)-0.49%
EPS NQ rev (1m)-45.4%
EPS NQ rev (3m)-48.02%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.09%
Revenue NQ rev (1m)9.66%
Revenue NQ rev (3m)9.66%
Revenue NY rev (1m)8.99%
Revenue NY rev (3m)8.99%
Valuation
Industry RankSector Rank
PE 4.07
Fwd PE 14.52
P/S 6.53
P/FCF N/A
P/OCF N/A
P/B 2.19
P/tB 2.2
EV/EBITDA N/A
EPS(TTM)3.68
EY24.6%
EPS(NY)1.03
Fwd EY6.89%
FCF(TTM)-1.74
FCFYN/A
OCF(TTM)-1.39
OCFYN/A
SpS2.29
BVpS6.82
TBVpS6.81
PEG (NY)N/A
PEG (5Y)0.09
Graham Number23.76
Profitability
Industry RankSector Rank
ROA -7.2%
ROE -8.69%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.51%
FCFM N/A
ROA(3y)-18.56%
ROA(5y)-10.68%
ROE(3y)-34.67%
ROE(5y)-16.28%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 230.92%
Cap/Sales 15.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 11.07
Quick Ratio 9.55
Altman-Z 6.27
F-Score3
WACC5.65%
ROIC/WACCN/A
Cap/Depr(3y)193.74%
Cap/Depr(5y)143.05%
Cap/Sales(3y)14.2%
Cap/Sales(5y)9.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.34%
EPS 3Y21.76%
EPS 5Y43.54%
EPS Q2Q%245.08%
EPS Next Y-90.2%
EPS Next 2Y-47.1%
EPS Next 3Y-37.25%
EPS Next 5Y-18.12%
Revenue 1Y (TTM)-20.5%
Revenue growth 3Y16.94%
Revenue growth 5Y25.05%
Sales Q2Q%-54.41%
Revenue Next Year124.61%
Revenue Next 2Y53.95%
Revenue Next 3Y27.81%
Revenue Next 5Y16.68%
EBIT growth 1Y-79.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year11.47%
EBIT Next 3Y17.2%
EBIT Next 5YN/A
FCF growth 1Y-98.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-102.3%
OCF growth 3YN/A
OCF growth 5YN/A

SHOULDER INNOVATIONS INC / SI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SHOULDER INNOVATIONS INC?

ChartMill assigns a fundamental rating of 4 / 10 to SI.


What is the valuation status for SI stock?

ChartMill assigns a valuation rating of 4 / 10 to SHOULDER INNOVATIONS INC (SI). This can be considered as Fairly Valued.


How profitable is SHOULDER INNOVATIONS INC (SI) stock?

SHOULDER INNOVATIONS INC (SI) has a profitability rating of 3 / 10.


What is the expected EPS growth for SHOULDER INNOVATIONS INC (SI) stock?

The Earnings per Share (EPS) of SHOULDER INNOVATIONS INC (SI) is expected to decline by -90.2% in the next year.


How sustainable is the dividend of SHOULDER INNOVATIONS INC (SI) stock?

The dividend rating of SHOULDER INNOVATIONS INC (SI) is 0 / 10 and the dividend payout ratio is 0%.